These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 33944714)
1. Artifactual hypoglycaemia in a patient with scleroderma and Raynaud's phenomenon. Osman R; Erasmus E; Lahri S; Moosajee F S Afr Med J; 2021 Feb; 111(2):13202. PubMed ID: 33944714 [No Abstract] [Full Text] [Related]
2. Scleroderma and Raynaud's phenomenon. BARNETT AJ Clin Rep; 1959; 9():33-74. PubMed ID: 13796900 [No Abstract] [Full Text] [Related]
3. Clinical impact of artifactual hypoglycaemia and its diagnosis at the bedside. Drenthen LCA; Verheggen RJHM; de Galan BE Rheumatology (Oxford); 2019 Sep; 58(9):1691-1692. PubMed ID: 31211383 [No Abstract] [Full Text] [Related]
5. Raynaud's phenomenon affecting the tongue of a patient with scleroderma. Bridges MJ; Kelly CA Ann Rheum Dis; 2002 May; 61(5):472. PubMed ID: 11959778 [No Abstract] [Full Text] [Related]
9. Transient global amnesia and Raynaud's phenomenon in scleroderma. Nishida A; Kaiya H; Uematsu M; Maeda M; Mori S; Wakabayashi S Acta Neurol Scand; 1990 Jun; 81(6):550-2. PubMed ID: 2220314 [TBL] [Abstract][Full Text] [Related]
19. Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. Mikhailidis DP; Hutton RA; Jeremy JY; Dandona P Br Med J (Clin Res Ed); 1986 May; 292(6533):1461. PubMed ID: 3087473 [No Abstract] [Full Text] [Related]
20. Raynaud's phenomenon in limited cutaneous systemic sclerosis. Bonnecaze AK BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26715139 [No Abstract] [Full Text] [Related] [Next] [New Search]